These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37345035)

  • 1. Characterization and Optimization of the Tumor Microenvironment in Patient-Derived Organotypic Slices and Organoid Models of Glioblastoma.
    Nickl V; Eck J; Goedert N; Hübner J; Nerreter T; Hagemann C; Ernestus RI; Schulz T; Nickl RC; Keßler AF; Löhr M; Rosenwald A; Breun M; Monoranu CM
    Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micro-Engineered Organoid-on-a-Chip Based on Mesenchymal Stromal Cells to Predict Immunotherapy Responses of HCC Patients.
    Zou Z; Lin Z; Wu C; Tan J; Zhang J; Peng Y; Zhang K; Li J; Wu M; Zhang Y
    Adv Sci (Weinh); 2023 Sep; 10(27):e2302640. PubMed ID: 37485650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic characteristics and drug screening among organoids derived from non-small cell lung cancer patients.
    Chen JH; Chu XP; Zhang JT; Nie Q; Tang WF; Su J; Yan HH; Zheng HP; Chen ZX; Chen X; Song MM; Yi X; Li PS; Guan YF; Li G; Deng CX; Rosell R; Wu YL; Zhong WZ
    Thorac Cancer; 2020 Aug; 11(8):2279-2290. PubMed ID: 32633046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-derived organoid culture in epithelial ovarian cancers-Techniques, applications, and future perspectives.
    Chan WS; Mo X; Ip PPC; Tse KY
    Cancer Med; 2023 Oct; 12(19):19714-19731. PubMed ID: 37776168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-derived organoid culture of gastric cancer for disease modeling and drug sensitivity testing.
    Zu M; Hao X; Ning J; Zhou X; Gong Y; Lang Y; Xu W; Zhang J; Ding S
    Biomed Pharmacother; 2023 Jul; 163():114751. PubMed ID: 37105073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the tumor microenvironment in malignant melanoma organoids during the development and metastasis of tumors.
    Zhou S; Lu J; Liu S; Shao J; Liu Z; Li J; Xiao W
    Front Cell Dev Biol; 2023; 11():1166916. PubMed ID: 37152280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomanufacturing of glioblastoma organoids exhibiting hierarchical and spatially organized tumor microenvironment via transdifferentiation.
    Park S; Avera AD; Kim Y
    Biotechnol Bioeng; 2022 Nov; 119(11):3252-3274. PubMed ID: 35869574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic Reprogramming in Human Cancer Patients and Patient-Derived Models.
    Fan TW; Higashi RM; Lane AN
    Cold Spring Harb Perspect Med; 2024 Jul; ():. PubMed ID: 39009444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Surgical and Colonoscopy Tissue to Establish Colorectal Patient-derived Organoids.
    Chen H; Yang Y; Shi J; Yan T; Wang J; Yang Y; Lu Q; Feng H; Du J; Cao Z; Weygant N
    Curr Cancer Drug Targets; 2024; 24(5):546-555. PubMed ID: 37997804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful Patient-Derived Organoid Culture of Gynecologic Cancers for Disease Modeling and Drug Sensitivity Testing.
    Bi J; Newtson AM; Zhang Y; Devor EJ; Samuelson MI; Thiel KW; Leslie KK
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34200645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-Derived Cancer Organoids for Precision Oncology Treatment.
    Pernik MN; Bird CE; Traylor JI; Shi DD; Richardson TE; McBrayer SK; Abdullah KG
    J Pers Med; 2021 May; 11(5):. PubMed ID: 34067714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cultivating Ex Vivo Patient-Derived Glioma Organoids Using a Tissue Chopper.
    Alsalkini M; Cibulková V; Breun M; Kessler AF; Schulz T; Cattaneo A; Wipplinger C; Hübner J; Ernestus RI; Nerreter T; Monoranu CM; Hagemann C; Löhr M; Nickl V
    J Vis Exp; 2024 Jan; (203):. PubMed ID: 38314829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient Derived Organoids (PDOs), Extracellular Matrix (ECM), Tumor Microenvironment (TME) and Drug Screening: State of the Art and Clinical Implications of Ovarian Cancer Organoids in the Era of Precision Medicine.
    Spagnol G; Sensi F; De Tommasi O; Marchetti M; Bonaldo G; Xhindoli L; Noventa M; Agostini M; Tozzi R; Saccardi C
    Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Use of Endometrial Cancer Patient-Derived Organoid Culture for Drug Sensitivity Testing Is Feasible.
    Girda E; Huang EC; Leiserowitz GS; Smith LH
    Int J Gynecol Cancer; 2017 Oct; 27(8):1701-1707. PubMed ID: 28683005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of a large-scale patient-derived high-risk colorectal adenoma organoid biobank for high-throughput and high-content drug screening.
    Luo Z; Wang B; Luo F; Guo Y; Jiang N; Wei J; Wang X; Tseng Y; Chen J; Zhao B; Liu J
    BMC Med; 2023 Sep; 21(1):336. PubMed ID: 37667332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using Organotypic Tissue Slices to Investigate the Microenvironment of Pancreatic Cancer: Pharmacotyping and Beyond.
    Weitz JR; Tiriac H; Hurtado de Mendoza T; Wascher A; Lowy AM
    Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models.
    Tsai S; McOlash L; Palen K; Johnson B; Duris C; Yang Q; Dwinell MB; Hunt B; Evans DB; Gershan J; James MA
    BMC Cancer; 2018 Mar; 18(1):335. PubMed ID: 29587663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring New Dimensions of Tumor Heterogeneity: The Application of Single Cell Analysis to Organoid-Based 3D In Vitro Models.
    Landon-Brace N; Li NT; McGuigan AP
    Adv Healthc Mater; 2023 Oct; 12(26):e2300903. PubMed ID: 37589373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The N
    Zhao R; Li B; Zhang S; He Z; Pan Z; Guo Q; Qiu W; Qi Y; Zhao S; Wang S; Chen Z; Zhang P; Guo X; Xue H; Li G
    Front Immunol; 2021; 12():653711. PubMed ID: 34354698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioblastoma Microenvironment and Invasiveness: New Insights and Therapeutic Targets.
    Erices JI; Bizama C; Niechi I; Uribe D; Rosales A; Fabres K; Navarro-Martínez G; Torres Á; San Martín R; Roa JC; Quezada-Monrás C
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.